Annual Cash & Cash Equivalents
$71.19 M
+$7.95 M+12.58%
December 31, 2024
Summary
- As of March 10, 2025, PLRX annual cash & cash equivalents is $71.19 million, with the most recent change of +$7.95 million (+12.58%) on December 31, 2024.
- During the last 3 years, PLRX annual cash & cash equivalents has risen by +$19.52 million (+37.79%).
- PLRX annual cash & cash equivalents is now -17.04% below its all-time high of $85.81 million, reached on December 31, 2019.
Performance
PLRX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$71.19 M
-$8.43 M-10.59%
December 31, 2024
Summary
- As of March 10, 2025, PLRX quarterly cash and cash equivalents is $71.19 million, with the most recent change of -$8.43 million (-10.59%) on December 31, 2024.
- Over the past year, PLRX quarterly cash and cash equivalents has stayed the same.
- PLRX quarterly cash and cash equivalents is now -60.11% below its all-time high of $178.46 million, reached on June 30, 2020.
Performance
PLRX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
PLRX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +12.6% | 0.0% |
| 3 y3 years | +37.8% | 0.0% |
| 5 y5 years | -17.0% | 0.0% |
PLRX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +111.3% | -37.7% | +184.0% |
| 5 y | 5-year | -17.0% | +111.3% | -60.1% | +184.0% |
| alltime | all time | -17.0% | +111.3% | -60.1% | +306.0% |
Pliant Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $71.19 M(+12.6%) | $71.19 M(-10.6%) |
| Sep 2024 | - | $79.62 M(-1.0%) |
| Jun 2024 | - | $80.39 M(-29.7%) |
| Mar 2024 | - | $114.30 M(+80.8%) |
| Dec 2023 | $63.23 M(+87.7%) | $63.23 M(+9.6%) |
| Sep 2023 | - | $57.68 M(+5.0%) |
| Jun 2023 | - | $54.95 M(-46.4%) |
| Mar 2023 | - | $102.53 M(+204.4%) |
| Dec 2022 | $33.69 M(-34.8%) | $33.69 M(-24.5%) |
| Sep 2022 | - | $44.62 M(+78.0%) |
| Jun 2022 | - | $25.07 M(-23.0%) |
| Mar 2022 | - | $32.55 M(-37.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $51.66 M(+1.5%) | $51.66 M(+14.2%) |
| Sep 2021 | - | $45.23 M(+28.5%) |
| Jun 2021 | - | $35.19 M(-30.7%) |
| Mar 2021 | - | $50.82 M(-0.1%) |
| Dec 2020 | $50.88 M(-40.7%) | $50.88 M(-7.9%) |
| Sep 2020 | - | $55.22 M(-69.1%) |
| Jun 2020 | - | $178.46 M(+57.4%) |
| Mar 2020 | - | $113.37 M(+32.1%) |
| Dec 2019 | $85.81 M(+40.8%) | $85.81 M(+323.3%) |
| Jun 2019 | - | $20.27 M(+15.6%) |
| Dec 2018 | $60.95 M | - |
| Dec 2018 | - | $17.53 M |
FAQ
- What is Pliant Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Pliant Therapeutics?
- What is Pliant Therapeutics annual cash & cash equivalents year-on-year change?
- What is Pliant Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Pliant Therapeutics?
- What is Pliant Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Pliant Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of PLRX is $71.19 M
What is the all time high annual cash & cash equivalents for Pliant Therapeutics?
Pliant Therapeutics all-time high annual cash & cash equivalents is $85.81 M
What is Pliant Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, PLRX annual cash & cash equivalents has changed by +$7.95 M (+12.58%)
What is Pliant Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of PLRX is $71.19 M
What is the all time high quarterly cash and cash equivalents for Pliant Therapeutics?
Pliant Therapeutics all-time high quarterly cash and cash equivalents is $178.46 M
What is Pliant Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, PLRX quarterly cash and cash equivalents has changed by $0.00 (0.00%)